Description
Background: The use of electronic daily intensive longitudinal methods to assess quality of life in the daily lives of oncology patients is gaining attention. However, a comprehensive overview on the use and capabilities of these methods in cancer care is currently lacking.Aim: This review aimed to describe how often, in what manner and to which success electronic daily intensive longitudinal methods have been used among breast and lung cancer patients.
Design: Scoping review.
Data sources: Electronic databases (PubMed, Embase, PsycINFO) were searched up to April 2022. We included studies reporting on the use of electronic daily intensive longitudinal methods among adults with breast or lung cancer. Data was extracted on population and study characteristics, study findings, and implementation of the method in research and clinical practice.
Results: We identified 1140 articles and included 42, reporting on 34 studies. Few studies specifically examined advanced-stage disease patients. Study aims and designs varied widely, but mostly concerned physical symptoms, anxiety and depression. Within-person variability enabled examination of associations among constructs within individuals. Participation, compliance and attrition rates seemed acceptable for most studies, although complete methodological reporting was often lacking. Factors influencing implementation were linked to both patient (e.g. confidence with system) and method factors (e.g. option to use personal devices).
Conclusion: Electronic daily intensive longitudinal methods hold promise to provide unique insights into the daily lives of cancer patients. Although they appear feasible and acceptable in some patient populations, future research should focus on understanding the optimal conditions for intensive monitoring.
| Period | 2023 |
|---|---|
| Event title | Society for Ambulatory Assessment conference 2023 |
| Event type | Conference |